Impact of academia–government collaboration on laboratory medicine standardization in South Korea: analysis of eight years creatinine proficiency testing experience

Author:

Lee Seunghoo1ORCID,Yu Joonsang1ORCID,Cho Chan-Ik2ORCID,Cho Eun-Jung3ORCID,Jeong Tae-Dong4ORCID,Kim Sollip1ORCID,Lee Woochang1ORCID,Chun Sail1ORCID,Min Won-Ki1ORCID

Affiliation:

1. Department of Laboratory Medicine , University of Ulsan, College of Medicine and Asan Medical Center , Seoul , South Korea

2. Division of Chronic Disease Prevention , Korea Disease Control and Prevention Agency , Cheongju-si , Chungcheongbuk-do , South Korea

3. Department of Laboratory Medicine, Hallym University Dongtan Sacred Heart Hospital , Hallym University College of Medicine , Hwaseong , South Korea

4. Department of Laboratory Medicine , Ewha Womans University College of Medicine , Seoul , South Korea

Abstract

Abstract Objectives To evaluate the performance of the Academia–Government Collaboration for Laboratory Medicine Standardization in Korea (KR-STDZN) based on data from KR-STDZN proficiency testing (KR-STDZN-PT) for creatinine over eight years (2015–2022). Methods We used KR-STDZN-PT data of creatinine tests from 2015 to 2022. Acceptance of the participating institutions’ test results was assessed by calculating the acceptance performance as absolute bias (absBias%), total coefficient of variance (tCV%), and total error (TE%) for each sample using six measurements from each institution and true values of each reference material. The test result was considered acceptable when absBias%, tCV%, and TE% were <5.10, <3.20, and <11.40 %, respectively. The proportion of acceptable institutions among all participating institutions in each round was defined as the acceptance rate. Improvements in absBias%, tCV%, and TE% were analyzed using creatinine concentration ranges in samples. Results The number of participating institutions increased from 2015 to 2017 but remained consistent since 2018. The acceptance rates for absBias% and TE% increased from 52.2 and 77.6 %, in 2015 and to 90.7 and 96.3 %, in 2022, respectively. The acceptance rate for tCV% remained in the 90 % range for eight years. When creatinine <3 mg/dL, mean absBias%, and mean TE% improved significantly in 2021–2022 compared to 2015–2016 (p<0.05). When creatinine >3 mg/dL, acceptance performance did not improve. Mean tCV% remained consistent annually regardless of creatinine concentration. No significant variations in test methods were observed. Conclusions The collaboration between academia and the government improved creatinine testing quality. Nevertheless, KR-STDZN must be expanded and refined.

Funder

The Korea Disease Control and Prevention Agency

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3